Matches in Nanopublications for { <http://www.w3.org/1999/02/22-rdf-syntax-ns#subject> ?p ?o ?g. }
- subject C0007561 "ceftriaxone" assertion.
- subject C4553887 "biologics" assertion.
- subject C4551445 "label" assertion.
- subject C4522130 "label" assertion.
- subject C3470573 "led" assertion.
- subject C2827499 "label" assertion.
- subject C1708698 "led" assertion.
- subject C1705425 "label" assertion.
- subject C1522485 "label" assertion.
- subject C0674432 "lopinavir" assertion.
- subject C0292818 "ritonavir" assertion.
- subject C0205423 "certain" assertion.
- subject C0181496 "label" assertion.
- subject C0035366 "retroviral" assertion.
- subject C0005515 "biologics" assertion.
- subject C0003404 "antiparasitics" assertion.
- subject C3665580 "antibody" assertion.
- subject C1879316 "transfusion" assertion.
- subject C1621287 "antibody" assertion.
- subject C1167408 "antibody" assertion.
- subject C0005841 "transfusion" assertion.
- subject C0003241 "antibody" assertion.
- subject C0355642 "prophylactic" assertion.
- subject C0009653 "prophylactic" assertion.
- subject C5399721 "receptor antagonist" assertion.
- subject C4721408 "receptor antagonist" assertion.
- subject C4543207 "receptor antagonist" assertion.
- subject C1522428 "recombinant interleukin-1" assertion.
- subject C4727483 "positive" assertion.
- subject C3812269 "positive" assertion.
- subject C2825490 "positive" assertion.
- subject C1514241 "positive" assertion.
- subject C1446409 "positive" assertion.
- subject C4045520 "eravacycline" assertion.
- subject C2001856 "carfilzomib" assertion.
- subject C1176306 "aprepitant" assertion.
- subject C0537894 "caspofungin" assertion.
- subject C0356164 "other antibiotics" assertion.
- subject C0207683 "nafamostat" assertion.
- subject C0145106 "teicoplanin" assertion.
- subject C0129975 "camostat" assertion.
- subject C0068788 "nitazoxanide" assertion.
- subject C0068314 "valrubicin" assertion.
- subject C0038425 "streptomycin" assertion.
- subject C0022322 "ivermectin" assertion.
- subject C0009316 "colistin" assertion.
- subject C1720467 "Only" assertion.
- subject C1720467 "Only" assertion.
- subject C1720467 "Only" assertion.
- subject C4521986 "oral" assertion.
- subject C1272919 "oral" assertion.
- subject C0442027 "oral" assertion.
- subject C0226896 "oral" assertion.
- subject C0220871 "linoleate" assertion.
- subject C0220871 "linoleate" assertion.
- subject C0125894 "linoleate" assertion.
- subject C0125894 "linoleate" assertion.
- subject C4321395 "dependent" assertion.
- subject C4318438 "MerTK" assertion.
- subject C3891660 "TAM" assertion.
- subject C1834582 "TAM" assertion.
- subject C1706554 "MerTK" assertion.
- subject C1705987 "pathways" assertion.
- subject C1705273 "function" assertion.
- subject C1704259 "pathways" assertion.
- subject C1701901 "dependent" assertion.
- subject C1521889 "TAM" assertion.
- subject C1364081 "MerTK" assertion.
- subject C1315032 "function" assertion.
- subject C1259418 "MerTK" assertion.
- subject C0851827 "dependent" assertion.
- subject C0687702 "remission" assertion.
- subject C0544452 "remission" assertion.
- subject C0429986 "dependent" assertion.
- subject C0429964 "dependent" assertion.
- subject C0410207 "TAM" assertion.
- subject C0079589 "TAM" assertion.
- subject C0039286 "TAM" assertion.
- subject C0039285 "TAM" assertion.
- subject C0031843 "function" assertion.
- subject C0024501 "maintain" assertion.
- subject C0019868 "homeostatic" assertion.